Deciphering GABBR1-centered drug targets to fight viral infection with preexisting diabetes

Xiangqi Li; Xuemei Zhao; Li Peng; Hong Du; Shiwei Chen; Xia Chen

doi:10.3724/abbs.2023249

Deciphering GABBR1-centered drug targets to fight viral infection with preexisting diabetes

Acta Biochim Biophys Sin (Shanghai). 2023 Dec 25;55(12):1999-2003. doi: 10.3724/abbs.2023249.

Authors

Xiangqi Li¹, Xuemei Zhao¹, Li Peng¹, Hong Du², Shiwei Chen³, Xia Chen¹

Affiliations

¹ Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China.
² Department of General Practice, Hudong Community Health Service Centre, Shanghai 200129, China.
³ Department of Intervention, Gongli Hospital, Naval Medical University, Shanghai 200135, China.

No abstract available

MeSH terms

Diabetes Mellitus* / drug therapy
Genetic Predisposition to Disease
Humans
Virus Diseases*

Grants and funding

This work was supported by the grants from the Key Specialty Construction Project of Pudong Health Bureau of Shanghai (No. PWZzk2022-05), the Special Clinical Research Project of Shanghai Health Commission (No.202040315) and Pudong New Area Science and Technology Commission of Shanghai (No. PKJ2023-Y29).